Skip to main content
Christopher Chen, MD, Oncology, Goodyear, AZ, City of Hope Phoenix

ChristopherChun ManChenMD

Oncology Goodyear, AZ

Hematologic Oncology

Assistant Clinical Professor, Department of Medical Oncology & Therapeutics Research, City of Hope

Overview of Dr. Chen

Dr. Christopher Chen is an oncologist in Goodyear, AZ and is affiliated with City of Hope Phoenix. He received his medical degree from University at Buffalo School of Medicine and has been in practice 8 years. He is one of 27 doctors at City of Hope Phoenix who specialize in Oncology. He has 7 publications and 21 citings.

Education & Training

  • Washington University in St. Louis
    Washington University in St. LouisA.B., A.B. in Finance and Biology, 1998 - 2022
  • University of Arizona College of Medicine-Tucson
    University of Arizona College of Medicine-TucsonFellowship, Hematology and Medical Oncology, 2014 - 2017
  • University of Arizona College of Medicine-Phoenix
    University of Arizona College of Medicine-PhoenixResidency, Internal Medicine, 2010 - 2013
  • Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo
    Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2010

Certifications & Licensure

  • ID State Medical License
    ID State Medical License 2023 - 2025
  • OH State Medical License
    OH State Medical License 2022 - 2024
  • AZ State Medical License
    AZ State Medical License 2013 - 2024
  • NM State Medical License
    NM State Medical License 2023 - 2024
  • GA State Medical License
    GA State Medical License 2022 - 2024
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Journal Articles

  • Molecular characterization of mouse gastric zymogenic cells.  
    Mills JC, Andersson N, Stappenbeck TS, Chen CC, Gordon JI, J Biol Chem 278: 46138-46145,, 2023
  • Cost and Outcome Analysis of Autologous Peripheral Blood Stem Cell Mobilization with Plerixafor and G-CSF Vs. Cyclophosphamide and G-CSF in Patients with Multiple Myel...  
    Chen C, Maher K, Campen C, McBride A, Migliano J, Anwer F, Yeager A, BMT Tandem Meeting, 2/2016
  • Prognostic Factors for Chronic Lymphocytic Leukemia.  
    Chen C, Puvvada S, Curr Hematol Malig Rep, 1/2016
  • Join now to see all

Hospital Affiliations